Page 41 - Read Online

Strassheim et al. Vessel Plus 2018;2:29 I http://dx.doi.org/10.20517/2574-1209.2018.44 Page 13 of 22

7. Kach J, Sethakorn N, Dulin NO. A finer tuning of G-protein signaling through regulated control of RGS proteins. Am J Physiol Heart
Circ Physiol 2012;303:H19-35.
8. Tan JL, Ravid S, Spudich JA. Control of nonmuscle myosins by phosphorylation. Annu Rev Biochem 1992;61:721-59.
9. Ikebe M, Hartshorne DJ. Phosphorylation of smooth muscle myosin at two distinct sites by myosin light chain kinase. J Biol Chem
1985;260:10027-31.
10. Amano M, Ito M, Kimura K, Fukata Y, Chihara K, Nakano T, Matsuura Y, Kaibuchi K. Phosphorylation and activation of myosin by
Rho-associated kinase (Rho-kinase). J Biol Chem 1996;271:20246-9.
11. Yamamura A. Pathological function of Ca2+-sensing receptor in pulmonary arterial hypertension. J Smooth Muscle Res 2014;50:8-17.
12. Smith KA, Ayon RJ, Tang H, Makino A, Yuan JX. Calcium-sensing receptor regulates cytosolic [Ca (2+) ] and plays a major role in the
development of pulmonary hypertension. Front Physiol 2016;7:517.
13. Ota H, Beutz MA, Ito M, Abe K, Oka M, McMurtry IF. S1P(4) receptor mediates S1P-induced vasoconstriction in normotensive and
hypertensive rat lungs. Pulm Circ 2011;1:399-404.
14. Aiello RJ, Bourassa PA, Zhang Q, Dubins J, Goldberg DR, De Lombaert S, Humbert M, Guignabert C, Cavasin MA, McKinsey TA,
Paralkar V. Tryptophan hydroxylase 1 inhibition impacts pulmonary vascular remodeling in two rat models of pulmonary hypertension.
J Pharmacol Exp Ther 2017;360:267-79.
15. Bhat L, Hawkinson J, Cantillon M, Reddy DG, Bhat SR, Laurent CE, Bouchard A, Biernat M, Salvail D. RP5063, a novel, multimodal,
serotonin receptor modulator, prevents Sugen 5416-hypoxia-induced pulmonary arterial hypertension in rats. Eur J Pharmacol
2017;810:83-91.
16. Liu Y, Ren W, Warburton R, Toksoz D, Fanburg BL. Serotonin induces Rho/ROCK-dependent activation of Smads 1/5/8 in pulmonary
artery smooth muscle cells. FASEB J 2009;23:2299-306.
17. Mori MX, Itsuki K, Hase H, Sawamura S, Kurokawa T, Mori Y, Inoue R. Dynamics of receptor-operated Ca(2+) currents through TRPC
channels controlled via the PI(4,5)P2-PLC signaling pathway. Front Pharmacol 2015;6:22.
18. Kong F, Ma L, Zou L, Meng K, Ji T, Zhang L, Zhang R, Jiao J. Alpha1-adrenergic receptor activation stimulates calcium entry and
proliferation via TRPC6 channels in cultured human mesangial cells. Cell Physiol Biochem 2015;36:1928-38.
19. Tanabe S, Kreutz B, Suzuki N, Kozasa T. Regulation of RGS-RhoGEFs by Galpha12 and Galpha13 proteins. Methods Enzymol
2004;390:285-94.
20. Mahavadi S, Nalli A, Al-Shboul O, Murthy KS. Inhibition of MLC20 phosphorylation downstream of Ca2+ and RhoA: a novel
mechanism involving phosphorylation of myosin phosphatase interacting protein (M-RIP) by PKG and stimulation of MLC phosphatase
activity. Cell Biochem Biophys 2014;68:1-8.
21. Horinouchi T, Higa T, Aoyagi H, Nishiya T, Terada K, Miwa S. Adenylate cyclase/cAMP/protein kinase A signaling pathway inhibits
endothelin type A receptor-operated Ca(2)(+) entry mediated via transient receptor potential canonical 6 channels. J Pharmacol Exp
Ther 2012;340:143-51.
22. Nalli AD, Kumar DP, Al-Shboul O, Mahavadi S, Kuemmerle JF, Grider JR, Murthy KS. Regulation of Gbetagammai-dependent PLC-
beta3 activity in smooth muscle: inhibitory phosphorylation of PLC-beta3 by PKA and PKG and stimulatory phosphorylation of
Galphai-GTPase-activating protein RGS2 by PKG. Cell Biochem Biophys 2014;70:867-80.
23. Huang J, Zhou H, Mahavadi S, Sriwai W, Murthy KS. Inhibition of Galphaq-dependent PLC-beta1 activity by PKG and PKA is
mediated by phosphorylation of RGS4 and GRK2. Am J Physiol Cell Physiol 2007;292:C200-8.
24. Zieba BJ, Artamonov MV, Jin L, Momotani K, Ho R, Franke AS, Neppl RL, Stevenson AS, Khromov AS, Chrzanowska-Wodnicka
M, Somlyo AV. The cAMP-responsive Rap1 guanine nucleotide exchange factor, Epac, induces smooth muscle relaxation by down-
regulation of RhoA activity. J Biol Chem 2011;286:16681-92.
25. Moon MY, Kim HJ, Kim JG, Lee JY, Kim J, Kim SC, Choi IG, Kim PH, Park JB. Small GTPase Rap1 regulates cell migration through
regulation of small GTPase RhoA activity in response to transforming growth factor-beta1. J Cell Physiol 2013;228:2119-26.
26. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM. Activation of nitric oxide synthase in endothelial cells by Akt-
dependent phosphorylation. Nature 1999;399:601-5.
27. Nishida M, Watanabe K, Sato Y, Nakaya M, Kitajima N, Ide T, Inoue R, Kurose H. Phosphorylation of TRPC6 channels at Thr69 is
required for anti-hypertrophic effects of phosphodiesterase 5 inhibition. J Biol Chem 2010;285:13244-53.
28. Murthy KS, Zhou H, Grider JR, Makhlouf GM. Inhibition of sustained smooth muscle contraction by PKA and PKG preferentially
mediated by phosphorylation of RhoA. Am J Physiol Gastrointest Liver Physiol 2003;284:G1006-16.
29. Rolli-Derkinderen M, Sauzeau V, Boyer L, Lemichez E, Baron C, Henrion D, Loirand G, Pacaud P. Phosphorylation of serine 188
protects RhoA from ubiquitin/proteasome-mediated degradation in vascular smooth muscle cells. Circ Res 2005;96:1152-60.
30. Luykenaar KD, Welsh DG. Activators of the PKA and PKG pathways attenuate RhoA-mediated suppression of the KDR current in
cerebral arteries. Am J Physiol Heart Circ Physiol 2007;292:H2654-63.
31. Omori K, Kotera J. Overview of PDEs and their regulation. Circ Res 2007;100:309-27.
32. Murthy KS. Contractile agonists attenuate cGMP levels by stimulating phosphorylation of cGMP-specific PDE5; an effect mediated by
RhoA/PKC-dependent inhibition of protein phosphatase 1. Br J Pharmacol 2008;153:1214-24.
33. Luo L, Zheng W, Lian G, Chen H, Li L, Xu C, Xie L. Combination treatment of adipose-derived stem cells and adiponectin attenuates
pulmonary arterial hypertension in rats by inhibiting pulmonary arterial smooth muscle cell proliferation and regulating the AMPK/
BMP/Smad pathway. Int J Mol Med 2018;41:51-60.
34. Li HH, Hsu HH, Chang GJ, Chen IC, Ho WJ, Hsu PC, Chen WJ, Pang JS, Huang CC, Lai YJ. Prostanoid EP4 agonist L-902,688
activates PPARgamma and attenuates pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol 2018;314:L349-L59.